Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group Portfolio 13F
Kahn Brothers Group Holdings Activity
- Portfolio value:
- $580.19M≈ (-$35M≈)
- Previous value:
- $614.81M≈
- # of changes:
- 34
- New positions:
- 0
- Reported for:
- 31 Dec 2014 (Q4)
- Latest filing date:
- 03 Feb 2015
Kahn Brothers Group has disclosed a total of 34 changes to the portfolio in the (2014 Q4) SEC report(s): increased the number of shares of 5 and decreased the number of shares of 29 position(s).
What stocks did Kahn Brothers Group buy in 2014 Q4?
During 2014 Q4 Kahn Brothers Group has purchased 5 securities: (BP) BP PLC-SPONS ADR (added shares +2.73%), (BB) BlackBerry Ltd (added shares +18.63%), (PTEN) Patterson-UTI Energy Inc (added shares +42.21%), (NVS) Novartis AG ADR (added shares +1.98%) and (BMY) Bristol-Myers Squibb Company (added shares +2.71%).
In the 2014 Q4 report(s) the following changes have been made to the top investments: (C) Citigroup Inc (reduced shares -3.10%), (MRK) Merck & Company Inc (reduced shares -5.08%), (PFE) Pfizer Inc (reduced shares -5.14%), (NYT) New York Times Company (reduced shares -6.69%) and (FLG) Flagstar Financial, Inc (reduced shares -4.14%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.